Cure8 research brief
Cure8 research brief
Colonoscopy and chromoendoscopy are common in IBD care; knowing the frequency and timing of complications helps patients and clinicians weigh risks and plan follow-up. The finding that chromoendoscopy was not linked to more short-term problems may reassure some patients undergoing dye-based exams.
Patients with IBD scheduled for colonoscopy/chromoendoscopy; gastroenterologists and endoscopy nurses; IBD clinic staff.
This journal abstract reports a prospective study of 482 adults who had lower endoscopy (including dye-based chromoendoscopy) at a Norwegian university hospital in early 2021. Patients were interviewed 7 days after the procedure and medical records were reviewed at 7 and 30 days to capture new symptoms, healthcare contacts, hospitalizations, or procedures.
The study found that minor complications (symptoms not requiring hospitalization) were common: 62% of interviewed patients reported such events within 7 days. Hospitalizations within 30 days occurred in 5% of patients.
In adjusted analyses, male sex and having chromoendoscopy were associated with lower odds of adverse events within 7 days; administration of butylscopolamine during the procedure was associated with higher odds of emergency hospital admission within 30 days.
These findings suggest that minor post-colonoscopy complaints are frequent, and that chromoendoscopy did not increase—and was associated with fewer—early adverse events in this cohort. The paper used telephone follow-up and record review to capture outcomes up to 30 days.
Summary is grounded in the article abstract (structured content depth: abstract). Single-center study and observational design mean associations may not be causal and may not generalize to all settings.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.